Physician profile
Sally M Smith
NPI 1851373153
$829.58
in general payments reported to CMS, 2019-2025
18 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.75 · 2020: $53.87 · 2021: $33.07 · 2022: $209 · 2023: $136 · 2024: $241 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $124.13 | 2022-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $103.01 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.18 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $70.30 | 2024-2025 | Qelbree |
| Corium, LLC | $58.46 | 2022-2023 | Azstarys |
| Cranial Technologies, INC | $50.94 | 2020-2024 | Doc Band |
| Sanofi Pasteur INC. | $50.34 | 2022-2023 | |
| Glaxosmithkline, LLC. | $41.14 | 2019-2023 | Bexsero |
| Kowa Pharmaceuticals America, INC. | $33.15 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $31.04 | 2025 | |
| Verrica Pharmaceuticals INC. | $26.91 | 2024 | Ycanth |
| Biomarin Pharmaceutical INC. | $23.17 | 2024 | Voxzogo 1.2mg |
| Abbott Laboratories | $21.99 | 2025 | Id Now Instrument |
| Sobi, INC | $20.99 | 2022 | |
| Phadia US INC. | $20.33 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $19.99 | 2024 | Spinraza |
| Ironshore Pharmaceuticals INC. | $19.80 | 2019 | |
| Kaleo, INC. | $18.71 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.